Raven biosciences ApS — Credit Rating and Financial Key Figures

Raven biosciences ApS (CVR number: 39085127) is a company from AARHUS. The company reported a net sales of 7.1 mDKK in 2023, demonstrating a decline of -44.3 % compared to the previous year. The operating profit percentage was at 10.4 % (EBIT: 0.7 mDKK), while net earnings were 429.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 10.8 %, which can be considered good and Return on Equity (ROE) was 11.6 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 53.8 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Raven biosciences ApS's liquidity measured by quick ratio was 2.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.